Latest Period
Q2 2026
CUSIP: G72245122
Latest Period
Q2 2026
Institutions Reporting
25
Shares (Excl. Options)
1,216,484
Price
$19.12
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 25 institutions filings for Q2 2026.
Security key
G72245122
Latest holder period
Q2 2026
13F holders
25
13D/G owners
2
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP G72245122:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Genetel Bioventures Ltd | 3.3% | $9,444,962 | 488,857 | Genetel Bioventures Ltd | 31 Mar 2026 | |||
| EASTSPRING INVESTMENTS (SINGAPORE) LTD | 3.8% | $2,225,408 | 427,963 | EASTSPRING INVESTMENTS (SINGAPORE) LIMITED | 30 Sep 2024 |
As of 30 Jun 2026, 25 institutional investors reported holding 1,216,484 shares of Prenetics Global Ltd - Class A Ordinary Shares, par value $0.0015 per share (PRE). This represents 8.2% of the company’s total 14,813,848 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,216,484 | $23,259,035 | -$14,988,292 | $19.12 | 25 |
| 2026 Q1 | 1,990,402 | $38,455,032 | +$5,908,593 | $19.32 | 33 |
| 2025 Q4 | 1,739,977 | $27,401,264 | +$6,722,321 | $15.75 | 32 |
| 2025 Q3 | 1,295,941 | $17,236,109 | +$1,887,610 | $13.30 | 15 |
| 2025 Q2 | 1,154,007 | $9,782,769 | +$82,255 | $8.51 | 10 |
| 2025 Q1 | 1,149,706 | $4,571,132 | +$40,846 | $3.92 | 9 |
| 2024 Q4 | 1,139,286 | $6,603,908 | +$157,350 | $5.80 | 9 |
| 2024 Q3 | 1,112,142 | $4,470,372 | -$323,702 | $4.00 | 8 |
| 2024 Q2 | 1,192,380 | $7,058,681 | -$967,203 | $5.92 | 7 |
| 2024 Q1 | 1,355,901 | $5,491,493 | +$1,931,498 | $4.05 | 8 |
| 2023 Q4 | 879,011 | $5,222,346 | +$5,222,346 | $5.91 | 5 |